Biotech Co. Accuses Citadel Securities, Others Of Spoofing

By Sarah Jarvis · December 1, 2022, 8:31 PM EST

Northwest Biotherapeutics Inc. on Thursday sued several broker-dealers including Citadel Securities LLC and Canaccord Genuity LLC in New York federal court for allegedly carrying out a spoofing scheme that repeatedly drove the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC et al

Case Number

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

December 01, 2022

Recent Articles By Sarah

December 16, 2024
Becton Dickinson To Pay SEC $175M Over Pump Claims
October 28, 2024
Masimo Sues Founder Over Alleged 'Empty Voting' Scheme
July 19, 2024
DaVita To Pay $34M In Medicare Kickback Whistleblower Suit
June 28, 2024
Ontrak Exec Conviction Shows Trading Plans Aren't Shields
April 15, 2024
Mental Health Co. Cerebral To Pay $7M Over Data Failures
March 12, 2024
2nd Circ. Revives Parts Of McKesson Whistleblower Suit
March 11, 2024
Pfizer Slams Ex-Compliance Officer's Whistleblower Claims
October 10, 2023
Justices Hint At Siding With Whistleblower Against UBS
October 06, 2023
5 Things To Know About High Court Whistleblower Case
September 13, 2023
Biz Groups Urge CFPB To Not Go After Medical Credit Cards